CVS
36
3
WMT
66
2
EBAY
40
-2
MDT
59
2
EW
46
10
MCK
49
3
UA
53
3
LNC
35
3
MTB
44
3
BAX
47
2
FSLR
47
-2
PM
56
6
STX
35
7
JNPR
67
2
HRL
42
-2
CNP
49
2
ABBV
53
3
PCAR
39
5
NTRS
50
6
AFL
32
2
CVS
36
3
WMT
66
2
EBAY
40
-2
MDT
59
2
EW
46
10
MCK
49
3
UA
53
3
LNC
35
3
MTB
44
3
BAX
47
2
FSLR
47
-2
PM
56
6
STX
35
7
JNPR
67
2
HRL
42
-2
CNP
49
2
ABBV
53
3
PCAR
39
5
NTRS
50
6
AFL
32
2
Financhill
Back

Bio-Path Holdings 10K Form

Buy
54

BPTH
Bio-Path Holdings

Last Price:
$1.16
Seasonality Move:
28.02%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-14 10Q BPTH/Bio-Path Holdings Quarterly
2023-11-14 10Q BPTH/Bio-Path Holdings Quarterly
2023-08-14 10Q BPTH/Bio-Path Holdings Quarterly
2023-05-11 10Q BPTH/Bio-Path Holdings Quarterly
2022-11-14 10Q BPTH/Bio-Path Holdings Quarterly
2022-08-15 10Q BPTH/Bio-Path Holdings Quarterly

Receive BPTH News And Ratings

See the #1 stock for the next 7 days that we like better than BPTH

BPTH Financial Statistics

Sales & Book Value

Annual Sales: $37K
Cash Flow: $-3.4M
Price / Cash Flow: 0
Annual Sales: $-0.19
Price / Book: 1.95

Profitability

EPS (TTM): -11.03000
Net Income (TTM): $-10.5M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Bio-Path Holdings Earnings Forecast

Key Bio-Path Holdings Financial Ratios

  • The Gross Profit Margin over the past 13 years for BPTH is 0.00%.
  • The Selling, General & Administrative Expenses for BPTH have been equal to 9,521.62% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 20 years have been positive in 8 years.

Bio-Path Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BPTH
CUSIP: 09057N
Website: biopathholdings.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BPTH Technical Analysis vs Fundamental Analysis

Buy
54
Bio-Path Holdings (BPTH) is a Buy

Is Bio-Path Holdings a Buy or a Sell?

  • Bio-Path Holdings stock is rated a Buy
    The current Bio-Path Holdings [BPTH] share price is $1.16. The Score for BPTH is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.